←
Nico Gort-Freitas826 posts
Nico Gort-Freitas avatar

Nico Gort-Freitas

@Nich

PhD in systems biology @Harvard @KleinLabHMS. Ex digital nomad @MinervaUni @sfiscience. Genomics + immunology + machine learning. Jazz 𝄢. 🇦🇷🇧🇷🤟

◷ Joined April 2009▧ 60 Photos and videos
Nico Gort-Freitas avatar
Nico Gort-Freitas@Nich·10 May 2024

The most important unexpected lesson of my PhD.

There’s a second layer I had to learn (and find other quant-turned-biologists I teach struggle with) which is to not overthink before trying something—that there are so many unexpected twists you hit the limit of what you can plan by thinking much earlier than you expect

Maria Brbic avatar
⟳ Nico Gort-Freitas retweeted
Maria Brbic@mariabrbic·16 Feb 2024

Our 🪐SATURN method is now out in @naturemethods! SATURN paves the way for universal cell embeddings, enabling integration of datasets across different species 🐒🐁🧍🐟🐸 Using protein language models, we encode biological meaning of genes in scRNA-seq datasets.

SATURN performs cross-species integration and analysis using both single-cell gene expression and protein representations generated by protein language models. @jure @YanayRosen @mariabrbic @yusufroohani nature.com/articles/s41592-0…

Lior Pachter avatar
⟳ Nico Gort-Freitas retweeted
Lior Pachter@lpachter·6 Oct 2023

"These methods can order a set of individual cells along a path, and assign a pseudotime value to each cell that represents where the cell is along that path. This can be a starting point for further analysis to determine gene expression programs driving cell phenotypes."

Post attachment
Nico Gort-Freitas avatar
Nico Gort-Freitas@Nich·16 Aug 2023

Another outstanding study by Mikaël's group! @RubenBill5 et al. disentangled key axes of variation in the TME and their influence on cancer prognosis, showing that CXCL9:SPP1 polarization in macrophages is more predictive of patient survival than M1:M2 🤯.

📢 Research Alert! 🧬🔬 🩺 We are super excited that our latest study, led by the great @RubenBill5 & Asa Wirapati, is out: science.org/doi/full/10.1126… We set out to shed some light on the tumor microenvironment and its impact on cancer progression. 🧵

Kalki Kukreja avatar
⟳ Nico Gort-Freitas retweeted
Kalki Kukreja@KalkiKukreja·31 Jul 2023

🎉 Excited to share a big part of my PhD work in @KleinLabHMS that took many, many years and my blood, sweat, and tears! 😅 We ask - What’s the role of cell division in the formation of initial cell types during early development ?🧐 biorxiv.org/content/10.1101/… 🧵 (1/14)

Allon Klein Lab avatar
⟳ Nico Gort-Freitas retweeted
Allon Klein Lab@KleinLabHMS·2 May 2023

scRNA-seq is great for non-model organisms—with just a transcriptome you can discover new cell types. But for many marine organisms there's one big problem: SALT 🧂 A solution from our awesome student Tal Scully (1/7🧵) biorxiv.org/content/10.1101/…

Christian McBride avatar
⟳ Nico Gort-Freitas retweeted
Christian McBride@mcbridesworld·16 Apr 2023

Ahmad Jamal was someone who always left me completely starstruck. I’ve stood in a room with him numerous times and never had the guts to say hello. His vibe was just too regal. Thank you, Mr. Jamal for all the music you gave us. 🙏🏾❤️ RIP.

Post attachment
Allon Klein Lab avatar
⟳ Nico Gort-Freitas retweeted
Allon Klein Lab@KleinLabHMS·30 Mar 2023

Shout out to @Nich, @jgungabeesoon, @Mate_Kiss on our paper doi.org/10.1016/j.cell.2023.… on heterogeneity in tumor neutrophils and why it matters. A great summary by @PittetLab below:

❔What is special about an immune system that successfully attacks tumors, compared to one that doesn’t? Our new study in @CellCellPress led by @jgungabeesoon, @Nich and @Mate_Kiss_ aimed to address this question. A joint work with the great @KleinLabHMS authors.elsevier.com/a/1gqie…

Nico Gort-Freitas avatar
Nico Gort-Freitas@Nich·30 Mar 2023

Thrilled to share our latest work elucidating the critical role of neutrophils in successful cancer immunotherapy, featured in @CellCellPress. authors.elsevier.com/c/1gqie…

❔What is special about an immune system that successfully attacks tumors, compared to one that doesn’t? Our new study in @CellCellPress led by @jgungabeesoon, @Nich and @Mate_Kiss_ aimed to address this question. A joint work with the great @KleinLabHMS authors.elsevier.com/a/1gqie…

Nico Gort-Freitas avatar
Nico Gort-Freitas@Nich·30 Mar 2023

Come learn about the business of biotech in our case study course led by HBS faculty and industry experts. All Harvard affiliates are invited to apply!

Are you interested in learning about biotechnology entrepreneurship? If so you should apply for the Crossover course! Crossover teaches trainees the HBS case study method and how to apply it to real-world scenarios centered around the biotechnology industry.

Post attachment